Futura Medical shares climb on upbeat revenue forecast and cash position

Futura Medical shares climb on upbeat revenue forecast and cash position Proactive uses images sourced from Shutterstock Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) shares rose as much as 10% in early trading after the company said it expects to report revenue of £1.7 million for 2025, ahead of earlier guidance. The Surrey-based healthcare group, known for its erectile dysfunction treatment Eroxon, ended the year with £3.4 million in cash following a £2.75 million fundraise in November. Futura anti ...